ABSTRACT
INTRODUCTION
Transvaginal sonography (TVS) is core to any ovarian cancer screening strategy. Its efficacy both as a first-and a second-line test is being evaluated in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) 1 and in several other ovarian cancer screening trials worldwide 2 -4 . Visualization of ovaries underpins the identification of abnormal ovarian morphology. However, ovarian visualization can be difficult in general-population screening that involves older postmenopausal women with decreasing ovarian size and lack of follicular activity. The Kentucky Ovarian Cancer Screening group, in their report on efficacy of TVS screening in asymptomatic women at a single center, showed that it was possible to visualize the ovaries in 79.2% of the 57 214 scans performed in 14 469 women (including premenopausal women with a family history of ovarian cancer) enrolled on the trial between 1987 and 1999 2 . A more recent study, of 515 asymptomatic postmenopausal women, has also reported similar visualization rates: 86.3% for the right ovary and 78% for the left ovary 5 . Of these 515 women, 481 attended for a repeat TVS 12 months later 6 . The right ovary was seen in 85.8% and the left ovary in 77.7% of women. For both scans, the right ovary was seen in 80% and the left ovary was seen in 68%. More variable visualization rates, of between 57% and 71%, have been reported in different subgroups from the ovarian screening arm of the Prostate Lung Colorectal and Ovarian Cancer (PLCO) study 7, 8 . Although there is some description of the baseline characteristics of the study populations, in none was the effect of confounding factors, such as hysterectomy, assessed on ovarian visualization. As TVS is likely to remain part of any ovarian cancer screening strategy, this is essential if we are to compare study results or develop quality assessment measures to assess sonographers. We report on factors impacting the visualization of ovaries in women undergoing TVS in the ultrasound scan arm of the UKCTOCS.
METHODS
The UKCTOCS is a randomized controlled trial of ovarian cancer screening of 202 638 postmenopausal women participants in the general population. The participants are allocated to a control group (no screening), a multimodal group (annual screening with CA 125 as a primary test and TVS as a secondary test) or an ultrasound scan group (annual screening with TVS) in a 2:1:1 ratio. Women were recruited through 13 trial centers located in National Health Service (NHS) Hospitals in England, Wales and Northern Ireland. Written consent was obtained from all participants. Women were included in the trial if they were postmenopausal (defined as >12 months amenorrhea following a natural or surgical menopause or >12 months of hormone replacement therapy commenced for menopausal symptoms) and were ≥ 50 and 70-74 years of age. They were excluded if they had a history of bilateral oophorectomy, active malignancy (women with a past history of malignancy were eligible if they had no documented persistent or recurrent disease), increased risk of ovarian cancer because of familial predisposition or a previous history of ovarian cancer. Following confirmation of eligibility, 50 639 women were randomized to the ultrasound scan arm. At recruitment, women completed a baseline questionnaire, which included age, lifestyle factors, and reproductive, medical and family histories (Table 1) . Women were sent a postal questionnaire 3.5 years after randomization in which information on education, smoking and alcohol use was obtained. Details of recruitment and design are described elsewhere 1, 9 .
A detailed ultrasound scan protocol 1 addressed all issues with regard to scanning, including technique, classification of morphological findings, further management algorithms and collection and storage of the ultrasound data. The majority of the scans (carried out from 2001 to 2007) were performed using the Kretz SA2000 (Kretztechnik AG, Zipf, Austria) ultrasound machine. For the main trial, annual scans were performed by Type 1 sonographers who were certified sonographers, trained midwives or doctors in the NHS trained in gynecological scanning. If the results of the annual scan were abnormal then women had a repeat scan, which was performed by Type 2 sonographers who were senior sonographers (mostly superintendent level), experienced certified gynecologists or radiologists. Where women found TVS unacceptable, transabdominal sonography (TAS) was performed.
At the annual screen visit, the sonographer initially ascertained whether the woman had previously undergone a hysterectomy or a unilateral oophorectomy. The first step on scanning was to decide if the ovaries were: (a) seen; (b) not seen, but a good view of the iliac vessels was obtained; and (c) not seen, with a poor view of the iliac vessels secondary to bowel, fibroids or other pelvic structures. Definitions of morphology and algorithms for the classification of scans and further management are detailed elsewhere 1 . All data obtained from scans were entered on the central Web-based trial-management system 9 . In this study, women in the ultrasound scan arm of the UKCTOCS who underwent TVS at the first annual screen were included. Those who only had transabdominal scans were excluded.
The UKCTOCS study was approved by the UK North West Multicentre Research Ethics Committees (North West MREC 00/8/34). It is registered as an International Standard Randomized Controlled Trial (no. ISRCTN22488978).
Statistical analysis
Frequency distributions of baseline characteristics of the population were derived. Visualization was defined as ovaries 'seen' and the rates were calculated based on all included scans. Visualization rates of the right and the left ovary were calculated separately. As they were proportionally similar, all further analyses were confined to visualization rates of the right ovary. All recorded factors (age, body mass index (BMI), hormone replacement therapy (HRT) use, previous hysterectomy, unilateral oophorectomy with intact uterus (LONH), presence of fibroids, years from menopause, previous contraceptive pill use, miscarriages, parity, infertility history, tubal ligation, ever smoker, alcohol use, educational qualification, personal history of breast cancer and ethnicity) were evaluated for their effect on visualization of ovaries. Logistic regression with backward stepwise elimination (probability of removal = 0.05) was used to determine which of the abovementioned variables were independently significant in predicting ovarian visualization rates. All analyses were undertaken using Stata 12 (StataCorp LP, College Station, TX, USA). The majority of women were white, one in five was obese, 18.7% had previously had a hysterectomy and 1.6% had undergone a unilateral oophorectomy ( Table 1) . The right ovary (RO) was visualized in 29 297 (66.8%) scans and the left ovary (LO) in 28 726 (65.5%) ( Table 2) . As the visualization of the RO and LO was proportionally similar, further analyses were limited to the RO. In women in whom the RO was visualized, the median age at the scan was 59.9 (IQR, 9.5) years. Visualization of the RO declined with increasing age (Figure 1a ; Table 1 ) and being overweight or obese (Figure 1b ; Table 1 ).
RESULTS

Between
In total, 40 801 women had complete data with regard to factors assessed and were included in the model. In 27 717 of these women, the right ovary was visualized. From the logistic regression model, age at scan, raised BMI, previous hysterectomy, previous tubal ligation and LONH were identified as significant predictors at the 5% level, with fibroids, history of infertility and age 
DISCUSSION
This is the largest study describing factors affecting ovarian visualization on TVS in postmenopausal women.
Our results show a 47% decrease in ovarian visualization in women who have previously undergone hysterectomy and a 5% decrease with each increasing year of age. A 78% decrease in visualization is noted in women who have an intact uterus but unilateral oophorectomy, an 11% decrease in those who have had tubal ligation, a 9% decrease in overweight women and a 29% decrease in obese women. A history of infertility has a 14% increase in visualization of the ovary. There is also a non-significant increase in visualization of ovaries, of 22% and 17%, respectively, in women of Black and Asian origin. The strengths of our study are the large sample size, involving participants from the general population, a multicenter design and performance of scans by over 100 sonographers, all of which increases the external validity of the findings. The two other major factors that can affect visualization are skill/experience of the individual sonographer and the overall quality of the team. While there are no studies comparing visualization rates with experience of sonographers, Timmerman et al. have shown that operator experience is a significant factor in accurately identifying malignant from benign lesions on ultrasound scans 10 . In an image review study of 300 women (166 premenopausal and 134 postmenopausal), an accuracy of 92% was achieved by the two most-experienced operators, while accuracy dropped to 82-87% for the less-experienced operators. Similarly, there was very good interobserver agreement between the two most-experienced operators but this varied with the less-experienced operators. It is also likely that organization and leadership of the team, together with training, support and monitoring of the sonographers, adds to the quality of scanning at any individual center. We are currently undertaking work which compares scanning between sonographers and trial centers and describes in detail the quantitative methods for quality assessment of TVS in postmenopausal women, adjusted for the non-subjective factors identified and quantified here to impact on ovarian visualization.
Our findings of decreased ovarian visualization with previous hysterectomy confirm the report from the PLCO trial that women with previous hysterectomy were less likely (47%) to have their ovaries seen in comparison with women who had no previous gynecological surgery of their ovaries (61%) 8 . The most likely reason for this is the loss of anatomical landmarks with the absence of the uterus, making it harder to identify the ovary. Changes in the relative position of the ovaries and in the position and size of the uterus, and the presence of fibroids, bowel in the pelvis and adhesions secondary to surgery could also impact on visualization. Except for the presence of fibroids, information on the other factors was not routinely recorded so we are unable to comment on their effect. Unlike previous reports, the presence of fibroids did not decrease visualization (although the evidence was not strong, being only just significant at the 5% level) but this could be a result of the fact that these would be atrophic in this postmenopausal cohort and were likely to have been of smaller size and asymptomatic in the past. We noted that unilateral oophorectomy in the absence of hysterectomy was also associated with a significant (78%) decrease in visualization of the remaining ovary. Previous data also suggest that women who have had unilateral oophorectomy with hysterectomy have an accelerated decline in the function of the remaining ovary and an earlier menopause than do women who have had a hysterectomy alone during the premenopausal period 11 . This should lead to a reduction in the size of the remaining ovary and reduced visualization. In the PLCO study, visualization of the ovary contralateral to the side of oophorectomy was also decreased (42%) when compared with women who had no previous gynecological surgery (61%) 8 . No difference in visualization of ovaries was observed between women who had previously undergone gynecological surgery (61%) and those who underwent sterilization (60%). However, in our study, an 11% decrease in visualization was noted in those who had undergone tubal ligation. It is difficult to speculate why this may be the case as the latter is a minor procedure; however, it is known to be associated with iatrogenic hydrosalpinx 12 and it is possible that this may have obscured the view of the ovary.
The visualization of ovaries was reduced in women with increasing age (a 5% decrease in the OR with each year), whereas increasing age at menopause improved visualization (although this was only marginally significant). Ovaries were visualized in 71% of 55-to 59-year-old women compared with 55% of women 70-74 years of age (Table 1) . This is similar to the PLCO study, which reported decreased visualization in older women and increased rates in those who attained menopause in later years (after 55 years of age) 8 . There was a significant decrease in visualization of ovaries with BMI >30. Increased fat leads to poor penetration of sound waves beyond the focal point, leading to poor views on ultrasound scans 13 . In TVS this is reduced as the transducer is closer to the pelvic structures, making them easier to visualize. However, transducer movement may be restricted secondary to thigh and vulval obesity, especially in morbidly obese women.
Unlike other factors, information on smoking and alcohol use were obtained from the follow-up questionnaire completed 3 to 4 years following the first scan. Although unlikely, these habits may have changed from the time when the first scan was performed to when the data were actually collected. Other limitations include a small proportion (3.3%) of women who underwent both TVS and TAS and in whom it was not possible to determine whether the ovaries were visualized on TAS or TVS as this was not separately documented. In addition, the proportion of Black (1.4%), Asian (0.9%) and other ethnic-minority (0.8%) women in the study was small. This might have led to the lack of significant difference in visualization rates of ovaries.
In conclusion, several factors affect visualization of ovaries on TVS, with previous hysterectomy, previous LONH, tubal ligation, BMI and age having the largest impacts. Adjustments for these factors are necessary when developing quality assurance for ovarian ultrasound scanning or comparing results between studies as their prevalence may differ between populations.
